Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: April 14th (14 Apr 2014)

Voices

Richard Lehman, BM, BCh, MRCGP

This week’s topics include TOPCAT, fibrinolysis for those with intermediate-risk PE, and more.

Avatar of Larry Husten, PHD

Burton Sobel, Towering Cardiologist, Dead at 75 (7 May 2013)

News

Burton Sobel, a towering scientist and cardiologist, died at home on May 3 at the age of 75. Sobel had been treated in the past for prostate cancer and had suffered a recurrence, but it is not known if this was the immediate cause of his death. Sobel was among the most powerful and influential…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Richard Lehman, BM, BCh, MRCGP

Selections from Richard Lehman’s Literature Review: April 16th (16 Apr 2013)

Voices

Richard Lehman, BM, BCh, MRCGP

This week’s topics include fibrinolysis or primary PCI in STEMI, the effect of lower sodium intake on health, and the effect of increased potassium intake on CV risk factors and disease.

Avatar of Frans

Fibrinolysis Now or Primary PCI Later? (14 Mar 2013)

Voices

Frans van de Werf, MD,PhD, Richard A. Lange, MD, MBA, and L. David Hillis, MD

CardioExchange’s Rick Lange and David Hillis ask Frans Van de Werf, principal investigator for the STREAM study, about his study group’s findings and their implications for clinical practice. THE STUDY In the STREAM trial, investigators compared two treatment strategies in STEMI patients presenting early after symptom onset who were unable to undergo primary PCI within…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Fibrinolysis May Benefit Late-Arriving STEMI Patients (10 Mar 2013)

News

For more of our ACC.13 coverage of late-breaking clinical trials, interviews with the authors of the most important research, and blogs from our fellows on the most interesting presentations at the meeting, check out our Coverage Headquarters. Although primary PCI has emerged as the best treatment for STEMI, most patients don’t receive this treatment within…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Rita F Redberg, MD, MSc

Thrombolysis Instead of Primary PCI (30 Nov 2011)

Voices

Rita F Redberg, MD, MSc

The latest analysis of 2009 CMS data for 13,776 STEMI patients of door-in to door-out (DIDO) time by Herrin and colleagues does not bring encouraging news. After many years of hard work to reduce DIDO time for patients who present at facilities without primary PCI capability, only a small fraction of patients (<10%) are transferred…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.

Avatar of Larry Husten, PHD

Long Transfer Delays for STEMI Patients at Most Hospitals Without Primary PCI (28 Nov 2011)

News

Fewer than 10% of STEMI patients eligible for PCI who arrive at a hospital without PCI capability are transferred within the recommended times, according to a new study published in the Archives of Internal Medicine. Although dramatic improvements in door-to-balloon times have been achieved in recent years in PCI-capable hospitals, the new report suggests that…

This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.